Sabra Healthcare REIT (SBRA) had its price target raised by Scotiabank from $20.00 to $21.00. They now have a "sector perform" rating on the stock.
Sabra Healthcare REIT (NASDAQ:SBRA) had its "neutral" rating reaffirmed by analysts at UBS Group AG.
Sabra Healthcare REIT (NASDAQ:SBRA) had its price target raised by analysts at Citizens Jmp from $22.00 to $23.00. They now have a "market outperform" rating on the stock.
Sabra Healthcare REIT (NASDAQ:SBRA) had its "buy" rating reaffirmed by analysts at Citigroup Inc..
Sabra Healthcare REIT (NASDAQ:SBRA) had its "neutral" rating reaffirmed by analysts at Cantor Fitzgerald.